nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—GART—telencephalon—malignant glioma	0.0151	0.0493	CbGeAlD
Pemetrexed—ATIC—embryo—malignant glioma	0.0126	0.0411	CbGeAlD
Pemetrexed—GART—medulla oblongata—malignant glioma	0.0119	0.0387	CbGeAlD
Pemetrexed—ATIC—brainstem—malignant glioma	0.0116	0.0377	CbGeAlD
Pemetrexed—ATIC—retina—malignant glioma	0.0112	0.0364	CbGeAlD
Pemetrexed—GART—midbrain—malignant glioma	0.0109	0.0354	CbGeAlD
Pemetrexed—GART—spinal cord—malignant glioma	0.0106	0.0345	CbGeAlD
Pemetrexed—Interstitial pneumonia—Temozolomide—malignant glioma	0.0106	0.0345	CcSEcCtD
Pemetrexed—ATIC—telencephalon—malignant glioma	0.0103	0.0335	CbGeAlD
Pemetrexed—Transient ischaemic attack—Temozolomide—malignant glioma	0.0101	0.033	CcSEcCtD
Pemetrexed—Febrile neutropenia—Carmustine—malignant glioma	0.00881	0.0286	CcSEcCtD
Pemetrexed—SLC46A1—spinal cord—malignant glioma	0.00861	0.028	CbGeAlD
Pemetrexed—GART—central nervous system—malignant glioma	0.00861	0.028	CbGeAlD
Pemetrexed—Febrile neutropenia—Temozolomide—malignant glioma	0.00851	0.0277	CcSEcCtD
Pemetrexed—DHFR—embryo—malignant glioma	0.00849	0.0276	CbGeAlD
Pemetrexed—GART—cerebellum—malignant glioma	0.00841	0.0274	CbGeAlD
Pemetrexed—Embolism—Temozolomide—malignant glioma	0.00798	0.0259	CcSEcCtD
Pemetrexed—DHFR—retina—malignant glioma	0.0075	0.0244	CbGeAlD
Pemetrexed—Interstitial lung disease—Carmustine—malignant glioma	0.00748	0.0243	CcSEcCtD
Pemetrexed—Thrombosis—Carmustine—malignant glioma	0.00748	0.0243	CcSEcCtD
Pemetrexed—ATIC—midbrain—malignant glioma	0.00738	0.024	CbGeAlD
Pemetrexed—DCK—embryo—malignant glioma	0.00734	0.0239	CbGeAlD
Pemetrexed—Interstitial lung disease—Temozolomide—malignant glioma	0.00723	0.0235	CcSEcCtD
Pemetrexed—ATIC—spinal cord—malignant glioma	0.0072	0.0234	CbGeAlD
Pemetrexed—SLC46A1—central nervous system—malignant glioma	0.00699	0.0227	CbGeAlD
Pemetrexed—TYMS—telencephalon—malignant glioma	0.00697	0.0227	CbGeAlD
Pemetrexed—DHFR—telencephalon—malignant glioma	0.0069	0.0225	CbGeAlD
Pemetrexed—GART—brain—malignant glioma	0.00683	0.0222	CbGeAlD
Pemetrexed—SLC46A1—cerebellum—malignant glioma	0.00683	0.0222	CbGeAlD
Pemetrexed—DCK—retina—malignant glioma	0.00649	0.0211	CbGeAlD
Pemetrexed—SLC29A1—telencephalon—malignant glioma	0.00625	0.0204	CbGeAlD
Pemetrexed—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00622	0.0202	CcSEcCtD
Pemetrexed—DCK—telencephalon—malignant glioma	0.00597	0.0194	CbGeAlD
Pemetrexed—ATIC—central nervous system—malignant glioma	0.00584	0.019	CbGeAlD
Pemetrexed—ATIC—cerebellum—malignant glioma	0.00571	0.0186	CbGeAlD
Pemetrexed—SLC46A1—brain—malignant glioma	0.00555	0.0181	CbGeAlD
Pemetrexed—DHFR—medulla oblongata—malignant glioma	0.00542	0.0177	CbGeAlD
Pemetrexed—Pulmonary embolism—Carmustine—malignant glioma	0.0053	0.0172	CcSEcCtD
Pemetrexed—Respiratory failure—Temozolomide—malignant glioma	0.00521	0.017	CcSEcCtD
Pemetrexed—Pulmonary embolism—Temozolomide—malignant glioma	0.00512	0.0167	CcSEcCtD
Pemetrexed—Skin exfoliation—Carmustine—malignant glioma	0.00506	0.0165	CcSEcCtD
Pemetrexed—TYMS—midbrain—malignant glioma	0.00501	0.0163	CbGeAlD
Pemetrexed—Neuropathy—Carmustine—malignant glioma	0.00497	0.0162	CcSEcCtD
Pemetrexed—DHFR—midbrain—malignant glioma	0.00496	0.0161	CbGeAlD
Pemetrexed—Skin exfoliation—Temozolomide—malignant glioma	0.00489	0.0159	CcSEcCtD
Pemetrexed—DHFR—spinal cord—malignant glioma	0.00484	0.0157	CbGeAlD
Pemetrexed—Neuropathy—Temozolomide—malignant glioma	0.00481	0.0156	CcSEcCtD
Pemetrexed—DCK—medulla oblongata—malignant glioma	0.00469	0.0153	CbGeAlD
Pemetrexed—ATIC—brain—malignant glioma	0.00464	0.0151	CbGeAlD
Pemetrexed—Sepsis—Carmustine—malignant glioma	0.0046	0.015	CcSEcCtD
Pemetrexed—DCK—midbrain—malignant glioma	0.00429	0.014	CbGeAlD
Pemetrexed—DCK—spinal cord—malignant glioma	0.00419	0.0136	CbGeAlD
Pemetrexed—TYMS—central nervous system—malignant glioma	0.00396	0.0129	CbGeAlD
Pemetrexed—DHFR—central nervous system—malignant glioma	0.00392	0.0128	CbGeAlD
Pemetrexed—TYMS—cerebellum—malignant glioma	0.00387	0.0126	CbGeAlD
Pemetrexed—DHFR—cerebellum—malignant glioma	0.00384	0.0125	CbGeAlD
Pemetrexed—SLC29A1—central nervous system—malignant glioma	0.00355	0.0116	CbGeAlD
Pemetrexed—Mood swings—Temozolomide—malignant glioma	0.00352	0.0115	CcSEcCtD
Pemetrexed—SLC29A1—cerebellum—malignant glioma	0.00347	0.0113	CbGeAlD
Pemetrexed—Dehydration—Temozolomide—malignant glioma	0.00346	0.0112	CcSEcCtD
Pemetrexed—DCK—central nervous system—malignant glioma	0.0034	0.0111	CbGeAlD
Pemetrexed—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00335	0.0109	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00335	0.0109	CcSEcCtD
Pemetrexed—Dysphagia—Carmustine—malignant glioma	0.00332	0.0108	CcSEcCtD
Pemetrexed—DCK—cerebellum—malignant glioma	0.00332	0.0108	CbGeAlD
Pemetrexed—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00328	0.0107	CcSEcCtD
Pemetrexed—Dysphagia—Temozolomide—malignant glioma	0.00321	0.0104	CcSEcCtD
Pemetrexed—Pancytopenia—Carmustine—malignant glioma	0.00316	0.0103	CcSEcCtD
Pemetrexed—TYMS—brain—malignant glioma	0.00315	0.0102	CbGeAlD
Pemetrexed—DHFR—brain—malignant glioma	0.00312	0.0101	CbGeAlD
Pemetrexed—Neutropenia—Carmustine—malignant glioma	0.00311	0.0101	CcSEcCtD
Pemetrexed—Pancytopenia—Temozolomide—malignant glioma	0.00305	0.00992	CcSEcCtD
Pemetrexed—Neutropenia—Temozolomide—malignant glioma	0.003	0.00977	CcSEcCtD
Pemetrexed—Renal failure—Carmustine—malignant glioma	0.00291	0.00948	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Carmustine—malignant glioma	0.0029	0.00945	CcSEcCtD
Pemetrexed—Stomatitis—Carmustine—malignant glioma	0.00289	0.0094	CcSEcCtD
Pemetrexed—Infestation NOS—Temozolomide—malignant glioma	0.00286	0.00932	CcSEcCtD
Pemetrexed—Infestation—Temozolomide—malignant glioma	0.00286	0.00932	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00284	0.00924	CcSEcCtD
Pemetrexed—SLC29A1—brain—malignant glioma	0.00282	0.00918	CbGeAlD
Pemetrexed—Neuropathy peripheral—Temozolomide—malignant glioma	0.00281	0.00913	CcSEcCtD
Pemetrexed—Stomatitis—Temozolomide—malignant glioma	0.00279	0.00908	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Temozolomide—malignant glioma	0.00271	0.00881	CcSEcCtD
Pemetrexed—DCK—brain—malignant glioma	0.0027	0.00877	CbGeAlD
Pemetrexed—Hepatitis—Temozolomide—malignant glioma	0.00257	0.00836	CcSEcCtD
Pemetrexed—Pharyngitis—Temozolomide—malignant glioma	0.00255	0.0083	CcSEcCtD
Pemetrexed—Urinary tract disorder—Temozolomide—malignant glioma	0.00254	0.00826	CcSEcCtD
Pemetrexed—Urethral disorder—Temozolomide—malignant glioma	0.00252	0.0082	CcSEcCtD
Pemetrexed—Eye disorder—Carmustine—malignant glioma	0.00249	0.00809	CcSEcCtD
Pemetrexed—Erythema multiforme—Temozolomide—malignant glioma	0.00243	0.00791	CcSEcCtD
Pemetrexed—Eye disorder—Temozolomide—malignant glioma	0.0024	0.00781	CcSEcCtD
Pemetrexed—Arrhythmia—Carmustine—malignant glioma	0.00238	0.00773	CcSEcCtD
Pemetrexed—Alopecia—Carmustine—malignant glioma	0.00235	0.00765	CcSEcCtD
Pemetrexed—Erythema—Carmustine—malignant glioma	0.00232	0.00753	CcSEcCtD
Pemetrexed—Malnutrition—Carmustine—malignant glioma	0.00232	0.00753	CcSEcCtD
Pemetrexed—Alopecia—Temozolomide—malignant glioma	0.00227	0.00739	CcSEcCtD
Pemetrexed—Erythema—Temozolomide—malignant glioma	0.00224	0.00728	CcSEcCtD
Pemetrexed—Malnutrition—Temozolomide—malignant glioma	0.00224	0.00728	CcSEcCtD
Pemetrexed—Dysgeusia—Temozolomide—malignant glioma	0.00219	0.00713	CcSEcCtD
Pemetrexed—Anaemia—Carmustine—malignant glioma	0.00214	0.00696	CcSEcCtD
Pemetrexed—Leukopenia—Carmustine—malignant glioma	0.00207	0.00674	CcSEcCtD
Pemetrexed—Anaemia—Temozolomide—malignant glioma	0.00207	0.00673	CcSEcCtD
Pemetrexed—Leukopenia—Temozolomide—malignant glioma	0.002	0.00652	CcSEcCtD
Pemetrexed—Hypertension—Carmustine—malignant glioma	0.002	0.0065	CcSEcCtD
Pemetrexed—Chest pain—Carmustine—malignant glioma	0.00197	0.00641	CcSEcCtD
Pemetrexed—Myalgia—Carmustine—malignant glioma	0.00197	0.00641	CcSEcCtD
Pemetrexed—Hypertension—Temozolomide—malignant glioma	0.00193	0.00628	CcSEcCtD
Pemetrexed—Myalgia—Temozolomide—malignant glioma	0.00191	0.0062	CcSEcCtD
Pemetrexed—Arthralgia—Temozolomide—malignant glioma	0.00191	0.0062	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00189	0.00615	CcSEcCtD
Pemetrexed—Oedema—Carmustine—malignant glioma	0.00189	0.00615	CcSEcCtD
Pemetrexed—Infection—Carmustine—malignant glioma	0.00188	0.00611	CcSEcCtD
Pemetrexed—Thrombocytopenia—Carmustine—malignant glioma	0.00185	0.00602	CcSEcCtD
Pemetrexed—Anaphylactic shock—Temozolomide—malignant glioma	0.00183	0.00594	CcSEcCtD
Pemetrexed—Oedema—Temozolomide—malignant glioma	0.00183	0.00594	CcSEcCtD
Pemetrexed—Infection—Temozolomide—malignant glioma	0.00181	0.0059	CcSEcCtD
Pemetrexed—Anorexia—Carmustine—malignant glioma	0.0018	0.00586	CcSEcCtD
Pemetrexed—Nervous system disorder—Temozolomide—malignant glioma	0.00179	0.00583	CcSEcCtD
Pemetrexed—Thrombocytopenia—Temozolomide—malignant glioma	0.00179	0.00582	CcSEcCtD
Pemetrexed—Skin disorder—Temozolomide—malignant glioma	0.00177	0.00577	CcSEcCtD
Pemetrexed—Anorexia—Temozolomide—malignant glioma	0.00174	0.00566	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00172	0.0056	CcSEcCtD
Pemetrexed—Dyspnoea—Carmustine—malignant glioma	0.00169	0.00548	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00166	0.00541	CcSEcCtD
Pemetrexed—Decreased appetite—Carmustine—malignant glioma	0.00164	0.00534	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Carmustine—malignant glioma	0.00163	0.00531	CcSEcCtD
Pemetrexed—Dyspnoea—Temozolomide—malignant glioma	0.00163	0.0053	CcSEcCtD
Pemetrexed—Constipation—Carmustine—malignant glioma	0.00162	0.00526	CcSEcCtD
Pemetrexed—Pain—Carmustine—malignant glioma	0.00162	0.00526	CcSEcCtD
Pemetrexed—Dyspepsia—Temozolomide—malignant glioma	0.00161	0.00523	CcSEcCtD
Pemetrexed—Decreased appetite—Temozolomide—malignant glioma	0.00159	0.00516	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00158	0.00513	CcSEcCtD
Pemetrexed—Fatigue—Temozolomide—malignant glioma	0.00157	0.00512	CcSEcCtD
Pemetrexed—Pain—Temozolomide—malignant glioma	0.00156	0.00508	CcSEcCtD
Pemetrexed—Constipation—Temozolomide—malignant glioma	0.00156	0.00508	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Carmustine—malignant glioma	0.00155	0.00503	CcSEcCtD
Pemetrexed—Body temperature increased—Carmustine—malignant glioma	0.00149	0.00486	CcSEcCtD
Pemetrexed—Abdominal pain—Carmustine—malignant glioma	0.00149	0.00486	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Temozolomide—malignant glioma	0.00149	0.00486	CcSEcCtD
Pemetrexed—Urticaria—Temozolomide—malignant glioma	0.00145	0.00472	CcSEcCtD
Pemetrexed—Body temperature increased—Temozolomide—malignant glioma	0.00144	0.0047	CcSEcCtD
Pemetrexed—Abdominal pain—Temozolomide—malignant glioma	0.00144	0.0047	CcSEcCtD
Pemetrexed—Hypersensitivity—Carmustine—malignant glioma	0.00139	0.00453	CcSEcCtD
Pemetrexed—Asthenia—Carmustine—malignant glioma	0.00136	0.00441	CcSEcCtD
Pemetrexed—Hypersensitivity—Temozolomide—malignant glioma	0.00135	0.00438	CcSEcCtD
Pemetrexed—Asthenia—Temozolomide—malignant glioma	0.00131	0.00426	CcSEcCtD
Pemetrexed—Diarrhoea—Carmustine—malignant glioma	0.00129	0.00421	CcSEcCtD
Pemetrexed—Pruritus—Temozolomide—malignant glioma	0.00129	0.0042	CcSEcCtD
Pemetrexed—Dizziness—Carmustine—malignant glioma	0.00125	0.00407	CcSEcCtD
Pemetrexed—Diarrhoea—Temozolomide—malignant glioma	0.00125	0.00406	CcSEcCtD
Pemetrexed—Dizziness—Temozolomide—malignant glioma	0.00121	0.00393	CcSEcCtD
Pemetrexed—Vomiting—Carmustine—malignant glioma	0.0012	0.00391	CcSEcCtD
Pemetrexed—Rash—Carmustine—malignant glioma	0.00119	0.00388	CcSEcCtD
Pemetrexed—Dermatitis—Carmustine—malignant glioma	0.00119	0.00387	CcSEcCtD
Pemetrexed—Vomiting—Temozolomide—malignant glioma	0.00116	0.00378	CcSEcCtD
Pemetrexed—Rash—Temozolomide—malignant glioma	0.00115	0.00375	CcSEcCtD
Pemetrexed—Dermatitis—Temozolomide—malignant glioma	0.00115	0.00374	CcSEcCtD
Pemetrexed—Nausea—Carmustine—malignant glioma	0.00112	0.00365	CcSEcCtD
Pemetrexed—Nausea—Temozolomide—malignant glioma	0.00108	0.00353	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00047	0.00122	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	0.00047	0.00122	CbGpPWpGaD
Pemetrexed—DHFR—Disease—BCAN—malignant glioma	0.000461	0.0012	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS1—malignant glioma	0.00046	0.00119	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000455	0.00118	CbGpPWpGaD
Pemetrexed—GART—Metabolism—NCOR1—malignant glioma	0.000451	0.00117	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00045	0.00117	CbGpPWpGaD
Pemetrexed—DHFR—G1/S Transition—MYC—malignant glioma	0.00045	0.00117	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TOP2A—malignant glioma	0.000447	0.00116	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—H3F3A—malignant glioma	0.000443	0.00115	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000442	0.00115	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.000436	0.00113	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000432	0.00112	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—BCHE—malignant glioma	0.000428	0.00111	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—YWHAE—malignant glioma	0.000427	0.00111	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—H3F3A—malignant glioma	0.000424	0.0011	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—SLC5A5—malignant glioma	0.000422	0.0011	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—PPARG—malignant glioma	0.000422	0.00109	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—COX8A—malignant glioma	0.000421	0.00109	CbGpPWpGaD
Pemetrexed—DHFR—Disease—DTX1—malignant glioma	0.000417	0.00108	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000416	0.00108	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ASMT—malignant glioma	0.00041	0.00107	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—JAG1—malignant glioma	0.0004	0.00104	CbGpPWpGaD
Pemetrexed—TYMS—G1/S Transition—MYC—malignant glioma	0.000392	0.00102	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FBXW7—malignant glioma	0.000391	0.00102	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TOP2A—malignant glioma	0.00039	0.00101	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—IDH2—malignant glioma	0.000387	0.001	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—H3F3A—malignant glioma	0.000386	0.001	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—BCAN—malignant glioma	0.000386	0.001	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	0.000386	0.001	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000383	0.000994	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTT1—malignant glioma	0.000382	0.000993	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000379	0.000983	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—YWHAE—malignant glioma	0.000372	0.000966	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CAV1—malignant glioma	0.000368	0.000954	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2B6—malignant glioma	0.000364	0.000944	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000364	0.000944	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000358	0.00093	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000358	0.00093	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS1—malignant glioma	0.000358	0.00093	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ASMT—malignant glioma	0.000358	0.000929	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000357	0.000927	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000353	0.000917	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000346	0.000897	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GSTP1—malignant glioma	0.00034	0.000883	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—BCAN—malignant glioma	0.000337	0.000874	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CG—malignant glioma	0.000335	0.000869	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—BCHE—malignant glioma	0.000333	0.000865	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—IDH1—malignant glioma	0.000333	0.000864	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CAT—malignant glioma	0.000331	0.000859	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—MYC—malignant glioma	0.000331	0.000858	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—SLC5A5—malignant glioma	0.000329	0.000854	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HEY2—malignant glioma	0.000327	0.000849	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—BRCA2—malignant glioma	0.000323	0.000839	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PPARG—malignant glioma	0.000323	0.000839	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SPHK1—malignant glioma	0.000322	0.000836	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000321	0.000832	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2B—malignant glioma	0.000321	0.000832	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IDH1—malignant glioma	0.000319	0.000829	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2C18—malignant glioma	0.000316	0.000819	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000313	0.000812	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NCOR1—malignant glioma	0.000313	0.000812	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—IDH2—malignant glioma	0.000311	0.000807	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000309	0.000803	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN2B—malignant glioma	0.000307	0.000796	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000303	0.000787	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HEY1—malignant glioma	0.000303	0.000786	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000301	0.000782	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CD—malignant glioma	0.000294	0.000764	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HIST1H3B—malignant glioma	0.000294	0.000763	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HES1—malignant glioma	0.000293	0.000759	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2B6—malignant glioma	0.000292	0.000759	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NCOR1—malignant glioma	0.000291	0.000755	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—PTEN—malignant glioma	0.000289	0.000751	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—BRCA2—malignant glioma	0.000282	0.000732	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2B—malignant glioma	0.00028	0.000726	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PDGFRA—malignant glioma	0.000279	0.000723	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—BIRC5—malignant glioma	0.000277	0.000718	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000272	0.000706	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—IDH2—malignant glioma	0.000271	0.000704	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.00027	0.000701	CbGpPWpGaD
Pemetrexed—DHFR—Disease—JAG2—malignant glioma	0.000269	0.000697	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TERT—malignant glioma	0.000268	0.000695	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—IDH1—malignant glioma	0.000267	0.000694	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTP1—malignant glioma	0.000265	0.000688	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SPHK1—malignant glioma	0.000259	0.000672	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CAT—malignant glioma	0.000258	0.000669	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CB—malignant glioma	0.000257	0.000666	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TERT—malignant glioma	0.000256	0.000665	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HLA-A—malignant glioma	0.000256	0.000665	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2B6—malignant glioma	0.000255	0.000662	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTT1—malignant glioma	0.000255	0.000662	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CAV1—malignant glioma	0.000255	0.000662	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTGS2—malignant glioma	0.000254	0.00066	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2C18—malignant glioma	0.000254	0.000658	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00025	0.00065	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PDGFB—malignant glioma	0.00025	0.000649	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGFR1—malignant glioma	0.000249	0.000646	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HIF1A—malignant glioma	0.000245	0.000636	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000245	0.000636	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NCOR1—malignant glioma	0.000244	0.000632	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—BIRC5—malignant glioma	0.000241	0.000626	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.00024	0.000624	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS1—malignant glioma	0.000239	0.000621	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CAV1—malignant glioma	0.000237	0.000615	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TERT—malignant glioma	0.000234	0.000607	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—IDH1—malignant glioma	0.000233	0.000606	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000233	0.000605	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CG—malignant glioma	0.000232	0.000603	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000231	0.000601	CbGpPWpGaD
Pemetrexed—DHFR—Disease—H3F3A—malignant glioma	0.000227	0.00059	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SPHK1—malignant glioma	0.000226	0.000586	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PPARG—malignant glioma	0.000224	0.000582	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—BAD—malignant glioma	0.000223	0.000579	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—BCHE—malignant glioma	0.000222	0.000577	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTEN—malignant glioma	0.000222	0.000576	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2C18—malignant glioma	0.000221	0.000574	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOTCH1—malignant glioma	0.000221	0.000573	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC5A5—malignant glioma	0.00022	0.00057	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CD80—malignant glioma	0.000216	0.000562	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APC—malignant glioma	0.000216	0.000561	CbGpPWpGaD
Pemetrexed—DHFR—Disease—JAG1—malignant glioma	0.000214	0.000556	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGF—malignant glioma	0.000214	0.000554	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000213	0.000552	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTPN11—malignant glioma	0.000212	0.000551	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FBXW7—malignant glioma	0.00021	0.000545	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000206	0.000534	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTT1—malignant glioma	0.000205	0.000532	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000205	0.000532	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CD—malignant glioma	0.000204	0.00053	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—BRAF—malignant glioma	0.000203	0.000527	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CAV1—malignant glioma	0.000199	0.000515	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT2—malignant glioma	0.000198	0.000513	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—malignant glioma	0.000197	0.000512	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS1—malignant glioma	0.000192	0.000499	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CD—malignant glioma	0.00019	0.000493	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—malignant glioma	0.000183	0.000476	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGF2—malignant glioma	0.000182	0.000472	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CG—malignant glioma	0.000181	0.000469	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTT1—malignant glioma	0.000179	0.000464	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—malignant glioma	0.000179	0.000464	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—BCHE—malignant glioma	0.000179	0.000464	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CB—malignant glioma	0.000178	0.000462	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MDM2—malignant glioma	0.000178	0.000461	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTP1—malignant glioma	0.000177	0.000459	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC5A5—malignant glioma	0.000176	0.000458	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—malignant glioma	0.000176	0.000458	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPARG—malignant glioma	0.000175	0.000453	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000174	0.000451	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CAT—malignant glioma	0.000172	0.000447	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MDM2—malignant glioma	0.00017	0.000441	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—RAF1—malignant glioma	0.00017	0.00044	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB2—malignant glioma	0.000168	0.000435	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS1—malignant glioma	0.000168	0.000435	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CB—malignant glioma	0.000166	0.00043	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN2B—malignant glioma	0.000164	0.000427	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—malignant glioma	0.000164	0.000426	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NCOR1—malignant glioma	0.000163	0.000422	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—malignant glioma	0.00016	0.000415	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CD—malignant glioma	0.000159	0.000413	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HES1—malignant glioma	0.000157	0.000407	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CA—malignant glioma	0.000156	0.000406	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NCOR1—malignant glioma	0.000156	0.000405	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—BCHE—malignant glioma	0.000156	0.000405	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MDM2—malignant glioma	0.000155	0.000403	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC5A5—malignant glioma	0.000154	0.0004	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTEN—malignant glioma	0.000154	0.000399	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PDGFRA—malignant glioma	0.000149	0.000388	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTEN—malignant glioma	0.000143	0.000371	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTP1—malignant glioma	0.000142	0.000369	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—malignant glioma	0.000139	0.000361	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CB—malignant glioma	0.000139	0.00036	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CAT—malignant glioma	0.000138	0.000359	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TERT—malignant glioma	0.000137	0.000357	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HLA-A—malignant glioma	0.000137	0.000357	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—malignant glioma	0.000137	0.000356	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PDGFB—malignant glioma	0.000134	0.000348	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGFR1—malignant glioma	0.000133	0.000346	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CAV1—malignant glioma	0.000133	0.000344	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HIF1A—malignant glioma	0.000131	0.000341	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NCOR1—malignant glioma	0.000131	0.000339	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—malignant glioma	0.000128	0.000332	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—malignant glioma	0.000128	0.000332	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CAV1—malignant glioma	0.000127	0.00033	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—malignant glioma	0.000124	0.000322	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTP1—malignant glioma	0.000124	0.000322	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—malignant glioma	0.000121	0.000315	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CAT—malignant glioma	0.000121	0.000313	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CG—malignant glioma	0.000121	0.000313	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTEN—malignant glioma	0.00012	0.000311	CbGpPWpGaD
Pemetrexed—DHFR—Disease—BAD—malignant glioma	0.00012	0.00031	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—malignant glioma	0.000119	0.000308	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOTCH1—malignant glioma	0.000118	0.000307	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPARG—malignant glioma	0.000116	0.000302	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—malignant glioma	0.000116	0.000302	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD80—malignant glioma	0.000116	0.000301	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APC—malignant glioma	0.000116	0.000301	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGF—malignant glioma	0.000114	0.000297	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NCOR1—malignant glioma	0.000114	0.000296	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTPN11—malignant glioma	0.000114	0.000295	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KRAS—malignant glioma	0.00011	0.000285	CbGpPWpGaD
Pemetrexed—DHFR—Disease—BRAF—malignant glioma	0.000109	0.000283	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CA—malignant glioma	0.000108	0.000281	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—malignant glioma	0.000108	0.000281	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CAV1—malignant glioma	0.000106	0.000276	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CD—malignant glioma	0.000106	0.000275	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT2—malignant glioma	0.000106	0.000275	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—malignant glioma	0.000102	0.000265	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CD—malignant glioma	0.000102	0.000264	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CA—malignant glioma	0.000101	0.000262	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGF2—malignant glioma	9.75e-05	0.000253	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CG—malignant glioma	9.7e-05	0.000252	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARG—malignant glioma	9.36e-05	0.000243	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CAV1—malignant glioma	9.29e-05	0.000241	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CB—malignant glioma	9.25e-05	0.00024	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—malignant glioma	9.16e-05	0.000238	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MDM2—malignant glioma	9.12e-05	0.000237	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RAF1—malignant glioma	9.09e-05	0.000236	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB2—malignant glioma	8.99e-05	0.000233	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—malignant glioma	8.9e-05	0.000231	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CB—malignant glioma	8.87e-05	0.00023	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—malignant glioma	8.86e-05	0.00023	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—malignant glioma	8.79e-05	0.000228	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CD—malignant glioma	8.53e-05	0.000221	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CG—malignant glioma	8.46e-05	0.00022	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CA—malignant glioma	8.45e-05	0.000219	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—malignant glioma	8.24e-05	0.000214	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARG—malignant glioma	8.17e-05	0.000212	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTEN—malignant glioma	7.99e-05	0.000207	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTEN—malignant glioma	7.67e-05	0.000199	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CD—malignant glioma	7.44e-05	0.000193	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CB—malignant glioma	7.43e-05	0.000193	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—malignant glioma	7.36e-05	0.000191	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—malignant glioma	6.9e-05	0.000179	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—malignant glioma	6.86e-05	0.000178	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CB—malignant glioma	6.49e-05	0.000168	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—malignant glioma	6.43e-05	0.000167	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTEN—malignant glioma	6.42e-05	0.000167	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—malignant glioma	6.37e-05	0.000165	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—malignant glioma	6.23e-05	0.000162	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KRAS—malignant glioma	5.89e-05	0.000153	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CA—malignant glioma	5.64e-05	0.000146	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTEN—malignant glioma	5.6e-05	0.000145	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CA—malignant glioma	5.41e-05	0.00014	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—malignant glioma	4.61e-05	0.00012	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CA—malignant glioma	4.53e-05	0.000118	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—malignant glioma	4.42e-05	0.000115	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CA—malignant glioma	3.95e-05	0.000103	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—malignant glioma	3.7e-05	9.61e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—malignant glioma	3.23e-05	8.38e-05	CbGpPWpGaD
